₹27
▼ -0.46 -1.68%
As of 27 Jul 2026 · delayed
NSE Listed
Mangalam Drugs and Organics Ltd. (MANGALAM)
Volume: 8,630Avg Vol 1W: 15,724Avg Vol 1M: 36,653.1552W Range:₹22.8₹93.08
Key Ratios
Checked 1d agoMarket Cap₹43 Cr
Current Price₹27
Previous Close₹27.46
High / Low (52w)₹93.08 / ₹22.8
Volume8,630
Avg Vol (1W)15,724
Avg Vol (1M)36,653.15
Stock P/E17.46
Book Value₹65.1
Dividend Yield0%
ROE-43.1%
ROA-14.1%
Revenue (TTM)₹319 Cr
Revenue Growth-13.7%
Profit Margin-19.1%
Total Debt₹9 Cr
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹-8.48
P/B0.42
Debt / Equity1.02
50 DMA₹28.35
200 DMA₹35.27
Day change-1.68%
Price Chart
₹27▼ 69.82% · 1Y
2025-07-292026-07-27
20-day avg volume: 37K shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 26% YoY.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹77 Cr | ₹80 Cr | ₹89 Cr | ₹73 Cr | ₹57 Cr | ₹50 Cr | ₹58 Cr | ₹67 Cr |
| EBITDA | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹-9 Cr | ₹-7 Cr | ₹-6 Cr | ₹-10 Cr |
| Net Profit | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹0 Cr | ₹-14 Cr | ₹-7 Cr | ₹-10 Cr | ₹-13 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹80 Cr | ₹89 Cr | ₹319 Cr | ₹73 Cr | ₹57 Cr | ₹50 Cr | ₹58 Cr | ₹67 Cr |
| EBITDA | ₹5 Cr | ₹5 Cr | ₹20 Cr | ₹6 Cr | ₹-9 Cr | ₹-7 Cr | ₹-6 Cr | ₹-10 Cr |
| Net Profit | ₹3 Cr | ₹1 Cr | ₹7 Cr | ₹0 Cr | ₹-14 Cr | ₹-7 Cr | ₹-10 Cr | ₹-13 Cr |
| EPS | — | — | 4.25 | — | — | — | — | — |
Balance Sheet
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Total Assets | ₹231 Cr | ₹264 Cr | ₹328 Cr | ₹358 Cr | ₹334 Cr | ₹366 Cr |
| Total Liabilities | ₹127 Cr | ₹133 Cr | ₹178 Cr | ₹206 Cr | ₹198 Cr | ₹217 Cr |
| Equity | ₹104 Cr | ₹131 Cr | ₹151 Cr | ₹152 Cr | ₹136 Cr | ₹149 Cr |
| Total Debt | ₹4 Cr | ₹7 Cr | ₹25 Cr | ₹19 Cr | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹37 Cr | ₹35 Cr | ₹38 Cr | ₹4 Cr | ₹43 Cr |
| Investing | ₹-31 Cr | ₹-27 Cr | ₹-22 Cr | ₹-12 Cr | ₹-19 Cr |
| Financing | ₹3 Cr | ₹3 Cr | ₹-17 Cr | ₹5 Cr | ₹-22 Cr |
| Free Cash Flow | ₹37 Cr | ₹35 Cr | ₹38 Cr | ₹4 Cr | ₹43 Cr |
Shareholding
Promoter 35.65% Institutions 0.11% Public 64.24%
Efficiency & Working Capital
ROCE8.1%
Interest Coverage1.3
Dividend Payout—
Debtor Days45 d
Inventory Days159 d
Payable Days105 d
Cash Conversion Cycle99 d
Working Capital Days204 d
Shareholding Details
As of 2026-06-30
Promoter35.7%
FII0.1%
DII0%
Institutions0.1%
Public64.2%
Promoter Pledge0%
No. of Shareholders24,465
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 35.6% | 35.7% | 35.7% |
| FIIs | 0.1% | 0.1% | 0.3% | 0.2% | 0.1% | 0.1% | 0.5% | 0.5% | 0.1% | 0.1% | 0.3% | 0.1% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 49.6% | 49.6% | 49.4% | 49.5% | 49.6% | 49.6% | 49.2% | 49.2% | 49.6% | 64.2% | 64% | 64.2% |
| Promoter Pledge | 17.5% | 18.1% | 17.6% | 14.9% | 10.3% | 11% | 13.2% | 13.2% | 34.6% | 7.1% | 0% | 0% |
| No. of Shareholders | 17,978 | 18,610 | 19,173 | 19,312 | 19,508 | 19,679 | 19,697 | 19,728 | 19,881 | 21,227 | 25,140 | 24,465 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Shree Rasbihari Trading & Investment Pvt Ltd | Shareholding of Promoter and Promoter Group | 6.2% | 9,82,563 |
| Shri Jb Pharma Private Limited | Shareholding of Promoter and Promoter Group | 6% | 9,50,000 |
| Dhoot Goverdhan Murlidhar | Shareholding of Promoter and Promoter Group | 3.2% | 5,11,792 |
| Shree Kishoriju Trading & Investment Pvt Ltd | Shareholding of Promoter and Promoter Group | 3.2% | 5,08,599 |
| Brijmohan Murlidhar Dhoot | Shareholding of Promoter and Promoter Group | 3.1% | 4,86,996 |
| Shweta Goverdhan Dhoot | Shareholding of Promoter and Promoter Group | 2.6% | 4,10,000 |
| Radhika Ajay Dhoot | Shareholding of Promoter and Promoter Group | 1.9% | 2,92,500 |
| Smita Aditya Dhoot | Shareholding of Promoter and Promoter Group | 1.9% | 2,92,500 |
| Rajkumari R. Dhoot | Shareholding of Promoter and Promoter Group | 1.7% | 2,75,948 |
| Raj Exports Pvt Ltd | Shareholding of Promoter and Promoter Group | 1.2% | 1,91,520 |
| Thakkalapalli Sampath Rao | Public Shareholding | 1% | 1,63,087 |
| Anish Dwivedi | Public Shareholding | 1% | 1,59,998 |
| Govardhan Murlidhar Dhoot | Shareholding of Promoter and Promoter Group | 1% | 1,55,330 |
| Rekha Goverdhan Dhoot | Shareholding of Promoter and Promoter Group | 0.9% | 1,46,760 |
| Ajay Ramniwas Dhoot | Shareholding of Promoter and Promoter Group | 0.9% | 1,38,687 |
| Jyoti Brijmohan Dhoot | Shareholding of Promoter and Promoter Group | 0.7% | 1,04,550 |
| Aditya R Dhoot | Shareholding of Promoter and Promoter Group | 0.6% | 89,225 |
| Brijmohan Murlidhar Dhoot | Shareholding of Promoter and Promoter Group | 0.5% | 77,473 |
| Rajkamal Sukhani | Shareholding of Promoter and Promoter Group | 0.2% | 28,520 |
| Chandrakanta Murlidhar Dhoot | Shareholding of Promoter and Promoter Group | 0% | 67 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Govardhan M Dhoot | Chairman / Executive Director / Managing Director | 2025 |
| Brijmohan Dhoot | E D & Wholetime Director | 2025 |
| Nidhi S. Mundada | Independent Non Exe. Director | 2025 |
| Praveen Saxena | Independent Non Exe. Director | 2025 |
| Rakesh K. Milwani | Non-Exec & Non-Independent Dir | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Bulk Drugs | ₹108 Cr | 96.1% |
| Chemicals & Others | ₹4 Cr | 3.9% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Domestic | ₹185 Cr | 81.4% |
| Export | ₹42 Cr | 18.6% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 30 | 16 | 16 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 24 | 0 | 0 | 1 | 5 | 31 |
| 2025 | 24 | 0 | 0 | 0 | 0 | 24 |
| 2025 | 0 | 0 | 0 | 1 | 1 | 4 |
Insider / Designated-Person Trades
11 recent disclosure(s)
SHREE KISHORIJU TRADING AND INVESTMENT PRIVATE LIMITEDRevoke · 1,500
AJAY RAMNIWAS DHOOTRevoke · 1,38,000
ADITYA RAMNIWAS DHOOTRevoke · 89,000
SHREE RASBIHARI TRADING AND INVESTMENTS PRIVATE LIMITEDRevoke · 1,73,000
SHREE KISHORIJU TRADING AND INVESTMENT PRIVATE LIMITEDRevoke · 1,37,484
SHRI JB PHARMA PRIVATE LIMITEDInvoke · 17,00,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Market30/03/2022 · 20,000
Company Information
🌐 www.mangalamdrugs.com ↗
📍 3rd Floor Rupam Building, 239 P D Mello Road, Mumbai, Maharashtra, 400001
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Manali PetrochemicalsManappuram Finance Ltd.Manav Infra Projects Ltd.Manba Finance LimitedMangal Credit N Fincorp LimitedMandeep Auto Industries LimitedMangalam Cement Ltd.Manilam Industries Ind LimitedMan Industries (India) Ltd.Man Infraconstruction Ltd.Mankind Pharma LimitedManomay Tex India Ltd.All “M” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search